293
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Efficacy of Lactulose versus Senna Plus Ispaghula Husk Among Patients with Pre-Dialysis Chronic Kidney Disease and Constipation: A Randomized Controlled Trial

, , ORCID Icon, &
Pages 313-319 | Published online: 07 Aug 2021

References

  • Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106(9):1582–91;quiz 1, 92. doi:10.1038/ajg.2011.164
  • Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004;99(4):750–759. doi:10.1111/j.1572-0241.2004.04114.x
  • Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491. doi:10.1053/j.gastro.2005.11.061
  • Zuvela J, Trimingham C, Le Leu R, et al. Gastrointestinal symptoms in patients receiving dialysis: a systematic review. Nephrology. 2018;23:718–727. doi:10.1111/nep.13243
  • Lee A, Lambert K, Byrne P, Lonergan M. Prevalence of constipation in patients with advanced kidney disease. J Ren Care. 2016;42:144–149. doi:10.1111/jorc.12157
  • Cano AE, Neil AK, Kang JY, et al. Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis. Am J Gastroenterol. 2007;102:1990–1997. doi:10.1111/j.1572-0241.2007.01321.x
  • Strid H, Simren M, Johansson AC, Svedlund J, Samuelsson O, Bjornsson ES. The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrol Dial Transplant. 2002;17:1434–1439. doi:10.1093/ndt/17.8.1434
  • Salmoirago-Blotcher E, Crawford S, Jackson E, Ockene J, Ockene I. Constipation and risk of cardiovascular disease among postmenopausal women. Am J Med. 2011;124:714–723. doi:10.1016/j.amjmed.2011.03.026
  • Sumida K, Molnar MZ, Potukuchi PK, et al. Constipation and risk of death and cardiovascular events. Atherosclerosis. 2019;281:114–120. doi:10.1016/j.atherosclerosis.2018.12.021
  • Sumida K, Molnar MZ, Potukuchi PK, et al. Constipation and incident CKD. J Am Soc Nephrol. 2017;28(4):1248–1258. doi:10.1681/ASN.2016060656
  • Ramos CI, Armani RG, Canziani ME, et al. Bowel habits and the association with uremic toxins in non–dialysis-dependent chronic kidney disease patients. J Ren Nutr. 2020;30(1):31–35. doi:10.1053/j.jrn.2019.02.004
  • Evenepoel P, Meijers BK, Bammens BR, Verbeke K. Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl. 2009;76:S12–S19. doi:10.1038/ki.2009.402
  • Wu MJ, Chang CS, Cheng CH, et al. Colonic transit time in long-term dialysis patients. Am J Kidney Dis. 2004;44:322–327. doi:10.1053/j.ajkd.2004.04.048
  • Tack J, Muller-Lissner S, Stanghellini V, et al. Diagnosis and treatment of chronic constipation–a European perspective. Neurogastroenterol Motil. 2011;23:697–710. doi:10.1111/j.1365-2982.2011.01709.x
  • Tayebi Khosroshahi H, Habibzadeh A, Khoshbaten M, Rahbari B, Chaichi P, Badiee AH. Lactulose for reduction of nitrogen products in patients with chronic kidney disease. Iran J Kidney Dis. 2014;8:377–381.
  • Marlett JA, Li BU, Patrow CJ, Bass P. Comparative laxation of psyllium with and without senna in an ambulatory constipated population. Am J Gastroenterol. 1987;82:333–337.
  • Kinnunen O, Winblad I, Koistinen P, Salokannel J. Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients. Pharmacology. 1993;47(Suppl 1):253–255. doi:10.1159/000139866
  • Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol. 2005;100:936–971. doi:10.1111/j.1572-0241.2005.40925.x
  • Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920–924. doi:10.3109/00365529709011203
  • Sumida K, Dashputre AA, Potukuchi PK, et al. Laxative use in patients with advanced chronic kidney disease transitioning to dialysis. Nephrol Dial Transplant. 2020. doi:10.1093/ndt/gfaa205
  • Sumida K, Yamagata K, Kovesdy CP. Constipation in CKD. Kidney Int Rep. 2020;5(2):121–134. doi:10.1016/j.ekir.2019.11.002
  • Quah HM, Ooi BS, Seow-Choen F, Sng KK, Ho KS. Prospective randomized crossover trial comparing fibre with lactulose in the treatment of idiopathic chronic constipation. Tech Coloproctol. 2006;10:111–114. doi:10.1007/s10151-006-0262-5
  • Passmore AP, Wilson-Davies K, Stoker C, Scott ME. Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination. BMJ. 1993;307:769–771. doi:10.1136/bmj.307.6907.769
  • Sutton D, Ovington S, Engel B. A multi-centre, randomised trial to assess whether increased dietary fibre intake (using a fibre supplement or high-fibre foods) produces healthy bowel performance and reduces laxative requirement in free living patients on peritoneal dialysis. J Ren Care. 2014;40:157–163. doi:10.1111/jorc.12056
  • Basilisco G, Coletta M. Chronic constipation: a critical review. Dig Liver Dis. 2013;45:886–893. doi:10.1016/j.dld.2013.03.016
  • Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011;60:209–218. doi:10.1136/gut.2010.227132
  • Tayebi-Khosroshahi H, Habibzadeh A, Niknafs B, et al. The effect of lactulose supplementation on fecal microflora of patients with chronic kidney disease; a randomized clinical trial. J Ren Inj Prev. 2016;5:162–167. doi:10.15171/jrip.2016.34